KARA FERRARO: Open Payments
NPI 1033972112 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,904 in 87 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,388 · 2025 $1,904
Food & beverage: $1,904
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $282 |
| Lilly USA, LLC | 9 | $189 |
| Otsuka America Pharmaceutical, Inc. | 8 | $176 |
| AstraZeneca Pharmaceuticals LP | 3 | $153 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $142 |
| Merck Sharp & Dohme LLC | 5 | $103 |
| Abbott Laboratories | 4 | $95 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $94 |
| Sumitomo Pharma America, Inc. | 4 | $93 |
| Phathom Pharmaceuticals, Inc. | 7 | $70 |
Products named: TRELEGY ELLIPTA, JARDIANCE, REXULTI, AIRSUPRA, FREESTYLE LIBRE 3, XIFAXAN, GEMTESA, MOUNJARO.
Industry payments across CT — which companies pay providers there.
